Results 271 to 280 of about 900,371 (377)

FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1485-1489, April 2025.
Abstract Aims Inflammation has been implicated in the pathogenesis of desmoplakin (DSP) cardiomyopathy, and retrospective studies have described abnormal myocardial fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in symptomatic patients eventually diagnosed with DSP cardiomyopathy.
Sanjay Divakaran, Vinay Randhawa, Usman A. Tahir, Matthew Robertson, Anam A. Waheed, Anna Perillo, Leanne Barrett, Ron Blankstein, Mark W. Feinberg, Marcelo F. Di Carli, Neal K. Lakdawala   +10 more
wiley   +1 more source

Effects of atrial fibrillation on prognosis of acute myocardial infarction.

, 1979
Erich H. Loewy
openalex   +1 more source

Dopamine‐induced increase in atrioventricular conduction in atrial fibrillation‐flutter [PDF]

, 1987
Daniel M. Gelfman, Joseph P. Ornato, Edgar R. Gonzalez   +2 more
openalex   +1 more source

Management of patients with chronic atrial fibrillation. [PDF]

, 1982
P Salhadin, M Bran, Michel De Marneffe, H Dénolin   +3 more
openalex   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

ESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini‐Kerth, Olivier Morel   +12 more
wiley   +1 more source

Surgical Methods and Devices for Atrial Fibrillation. [PDF]

Rev Cardiovasc Med
Yu Y, Jiang Q.
europepmc   +1 more source

Fast atrial fibrillation induced by azathioprine [PDF]

, 1985
Pascal C. Chijioke
openalex   +1 more source

2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS.

Revista Española de Cardiología, 2017
P. Kirchhof, S. Benussi, D. Kotecha, A. Ahlsson, D. Atar, B. Casadei, M. Castellà, H. Diener, H. Heidbuchel, J. Hendriks, G. Hindricks, A. Manolis, J. Oldgren, Bogdan Alexandru Popescu, U. Schotten, B. V. Van putte, P. Vardas   +16 more
semanticscholar   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Concomitant Diabetes and Atrial Fibrillation: Epicardial Fat and Macrophage-Related Mechanisms. [PDF]

Diabetes Metab Res Rev
Al-Rubaye S, Rodríguez-Mañero M, Ramón González-Juanatey J, Eiras S.   +3 more
europepmc   +1 more source